| Highly efficient endogenous human gene correction using designed zinc-finger nucleases FD Urnov, JC Miller, YL Lee, CM Beausejour, JM Rock, S Augustus, ... Nature 435 (7042), 646, 2005 | 1674 | 2005 |
| Chimeric nucleases stimulate gene targeting in human cells MH Porteus, D Baltimore Science 300 (5620), 763-763, 2003 | 818 | 2003 |
| Rapid “open-source” engineering of customized zinc-finger nucleases for highly efficient gene modification ML Maeder, S Thibodeau-Beganny, A Osiak, DA Wright, RM Anthony, ... Molecular cell 31 (2), 294-301, 2008 | 779 | 2008 |
| Gene targeting using zinc finger nucleases MH Porteus, D Carroll Nature biotechnology 23 (8), 967, 2005 | 714 | 2005 |
| Spatially restricted expression of Dlx-1, Dlx-2 (Tes-1), Gbx-2, and Wnt-3 in the embryonic day 12.5 mouse forebrain defines potential transverse and longitudinal segmental … A Bulfone, L Puelles, MH Porteus, MA Frohman, GR Martin, ... Journal of Neuroscience 13 (7), 3155-3172, 1993 | 570 | 1993 |
| Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells J Zou, ML Maeder, P Mali, SM Pruett-Miller, S Thibodeau-Beganny, ... Cell stem cell 5 (1), 97-110, 2009 | 526 | 2009 |
| Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells S Durai, M Mani, K Kandavelou, J Wu, MH Porteus, S Chandrasegaran Nucleic acids research 33 (18), 5978-5990, 2005 | 516 | 2005 |
| Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells A Hendel, RO Bak, JT Clark, AB Kennedy, DE Ryan, S Roy, I Steinfeld, ... Nature biotechnology 33 (9), nbt. 3290, 2015 | 419 | 2015 |
| Activation of proto-oncogenes by disruption of chromosome neighborhoods D Hnisz, AS Weintraub, DS Day, AL Valton, RO Bak, CH Li, J Goldmann, ... Science 351 (6280), 1454-1458, 2016 | 412 | 2016 |
| Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States A Kwan, RS Abraham, R Currier, A Brower, K Andruszewski, JK Abbott, ... Jama 312 (7), 729-738, 2014 | 376 | 2014 |
| An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level DE Bauer, SC Kamran, S Lessard, J Xu, Y Fujiwara, C Lin, Z Shao, ... Science 342 (6155), 253-257, 2013 | 376 | 2013 |
| Transplantation outcomes for severe combined immunodeficiency, 2000–2009 SY Pai, BR Logan, LM Griffith, RH Buckley, RE Parrott, CC Dvorak, ... New England Journal of Medicine 371 (5), 434-446, 2014 | 374 | 2014 |
| CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells DP Dever, RO Bak, A Reinisch, J Camarena, G Washington, CE Nicolas, ... Nature 539 (7629), 384, 2016 | 332 | 2016 |
| Use of chimeric nucleases to stimulate gene targeting D Baltimore, M Porteus US Patent 9,447,434, 2016 | 260 | 2016 |
| MOF and histone H4 acetylation at lysine 16 are critical for DNA damage response and double-strand break repair GG Sharma, S So, A Gupta, R Kumar, C Cayrou, N Avvakumov, U Bhadra, ... Molecular and cellular biology 30 (14), 3582-3595, 2010 | 236 | 2010 |
| Isolation and characterization of a novel cDNA clone encoding a homeodomain that is developmentally regulated in the ventral forebrain MH Porteus, A Bulfone, RD Ciaranello, JLR Rubenstein Neuron 7 (2), 221-229, 1991 | 225 | 1991 |
| Human SMC5/6 complex promotes sister chromatid homologous recombination by recruiting the SMC1/3 cohesin complex to double‐strand breaks PR Potts, MH Porteus, H Yu The EMBO journal 25 (14), 3377-3388, 2006 | 221 | 2006 |
| The mouse Dlx-2 (Tes-1) gene is expressed in spatially restricted domains of the forebrain, face and limbs in midgestation mouse embryos A Bulfone, HJ Kim, L Puelles, MH Porteus, JF Grippo, JLR Rubenstein Mechanisms of development 40 (3), 129-140, 1993 | 221 | 1993 |
| Standardized reagents and protocols for engineering zinc finger nucleases by modular assembly DA Wright, S Thibodeau-Beganny, JD Sander, RJ Winfrey, AS Hirsh, ... Nature protocols 1 (3), 1637, 2006 | 219 | 2006 |
| Mammalian gene targeting with designed zinc finger nucleases MH Porteus Molecular Therapy 13 (2), 438-446, 2006 | 214 | 2006 |
